The emerging treatment of the medication represents a major advance in the handling of the condition. Unlike existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone https://tirzepatide-peptide641470.qodsblog.com/42232959/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment